Timothy G Robinson

CIK 1577215 · View on SEC EDGAR ↗

Insider

First SEC filing: Feb. 21, 2020 · Latest: Feb. 21, 2020

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 28 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Feb. 20, 2020 MED F 220 $101.45 $22,319 47,214 Direct -0.46% Disposed -88.7% (price as of 2026-08-20)
Feb. 19, 2020 MED A 1,655 — — 47,434 Direct +3.62% Acquired (price as of 2026-08-20)
Feb. 20, 2019 MED A 1,306 — — 26,624 Direct +5.16% Acquired (price as of 2026-08-20)
Feb. 15, 2019 MED F 283 $132.82 $37,588 25,318 Direct -1.11% Disposed -91.4% (price as of 2026-08-20)
Feb. 7, 2019 MED F 170 $127.07 $21,602 25,601 Direct -0.66% Disposed -91.0% (price as of 2026-08-20)
Nov. 7, 2018 MED M 2,500 — — 5,000 Direct -33.33% Disposed (price as of 2026-08-20)
Nov. 7, 2018 MED F 1,437 $153.31 $220,306 25,771 Direct -5.28% Disposed -92.5% (price as of 2026-08-20)
Nov. 7, 2018 MED M 2,500 $44.73 $111,825 27,208 Direct +10.12% Acquired -74.4% (price as of 2026-08-20)
Feb. 19, 2018 MED F 534 $69.11 $36,905 24,708 Direct -2.12% Disposed -83.4% (price as of 2026-08-20)
Feb. 16, 2018 MED F 282 $69.11 $19,489 25,242 Direct -1.10% Disposed -83.4% (price as of 2026-08-20)
Feb. 7, 2018 MED A 4,500 — — 4,500 Direct — Acquired (price as of 2026-08-20)
Feb. 7, 2018 MED A 1,280 — — 25,524 Direct +5.28% Acquired (price as of 2026-08-20)
Dec. 31, 2017 MED F 3,800 $69.81 $265,278 24,244 Direct -13.55% Disposed -83.6% (price as of 2026-08-20)
Feb. 19, 2017 MED F 1,067 $45.07 $48,090 28,044 Direct -3.67% Disposed -74.6% (price as of 2026-08-20)
Feb. 16, 2017 MED A 7,500 — — 7,500 Direct — Acquired (price as of 2026-08-20)
Feb. 16, 2017 MED A 37,950 — — 37,950 Direct — Acquired (price as of 2026-08-20)
Feb. 16, 2017 MED A 2,120 — — 29,111 Direct +7.85% Acquired (price as of 2026-08-20)
Feb. 16, 2017 MED A 9,500 — — 26,991 Direct +54.31% Acquired (price as of 2026-08-20)
Dec. 31, 2016 MED F 2,250 $41.63 $93,668 17,491 Direct -11.40% Disposed -72.5% (price as of 2026-08-20)
Feb. 19, 2016 MED F 1,600 $29.52 $47,232 19,741 Direct -7.50% Disposed -61.2% (price as of 2026-08-20)
Feb. 4, 2016 MED A 5,625 — — 21,341 Direct +35.79% Acquired (price as of 2026-08-20)
Dec. 31, 2015 MED F 2,000 $30.38 $60,760 15,716 Direct -11.29% Disposed -62.3% (price as of 2026-08-20)
Feb. 19, 2015 MED F 1,067 $32.50 $34,678 17,716 Direct -5.68% Disposed -64.8% (price as of 2026-08-20)
Feb. 17, 2015 MED A 5,000 — — 18,783 Direct +36.28% Acquired (price as of 2026-08-20)
Jan. 1, 2015 MED F 1,500 $33.55 $50,325 13,783 Direct -9.81% Disposed -65.9% (price as of 2026-08-20)
March 25, 2014 MED F 467 $28.97 $13,529 15,283 Direct -2.97% Disposed -60.5% (price as of 2026-08-20)
Feb. 5, 2014 MED A 3,750 — — 15,750 Direct +31.25% Acquired (price as of 2026-08-20)
Feb. 19, 2013 MED A 12,000 — — 12,000 Direct — Acquired (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Nov. 7, 2018 MED Stock Options Common Stock (2,500) $44.73 Feb. 16, 2027 2,500 Disposed
Feb. 7, 2018 MED Stock Options Common Stock (4,500) $66.68 Feb. 7, 2028 4,500 Acquired
Feb. 16, 2017 MED Stock Options Common Stock (7,500) $44.73 Feb. 16, 2027 7,500 Acquired
Feb. 16, 2017 MED Performance Restricted Stock Units Common Stock (37,950) — — 37,950 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

MED

CFO
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2020 — — — — — — — —
2019 — — — — — — — —

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.